IL114984A - Pharmaceutical composition useful for making an oral extended release gepirone dosage form - Google Patents
Pharmaceutical composition useful for making an oral extended release gepirone dosage formInfo
- Publication number
- IL114984A IL114984A IL11498495A IL11498495A IL114984A IL 114984 A IL114984 A IL 114984A IL 11498495 A IL11498495 A IL 11498495A IL 11498495 A IL11498495 A IL 11498495A IL 114984 A IL114984 A IL 114984A
- Authority
- IL
- Israel
- Prior art keywords
- extended release
- making
- oral extended
- pharmaceutical composition
- dosage form
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Electroluminescent Light Sources (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/301,281 US5478572A (en) | 1994-09-06 | 1994-09-06 | Gepirone dosage form |
Publications (2)
Publication Number | Publication Date |
---|---|
IL114984A0 IL114984A0 (en) | 1995-12-08 |
IL114984A true IL114984A (en) | 1999-10-28 |
Family
ID=23162703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11498495A IL114984A (en) | 1994-09-06 | 1995-08-17 | Pharmaceutical composition useful for making an oral extended release gepirone dosage form |
Country Status (25)
Country | Link |
---|---|
US (1) | US5478572A (fi) |
EP (1) | EP0700680B1 (fi) |
JP (1) | JP4540756B2 (fi) |
KR (1) | KR100380806B1 (fi) |
CN (1) | CN1096858C (fi) |
AT (1) | ATE186462T1 (fi) |
AU (1) | AU702282B2 (fi) |
CA (1) | CA2157323C (fi) |
CY (1) | CY2222B1 (fi) |
CZ (1) | CZ286417B6 (fi) |
DE (1) | DE69513254T2 (fi) |
DK (1) | DK0700680T3 (fi) |
ES (1) | ES2142432T3 (fi) |
FI (1) | FI117319B (fi) |
GR (1) | GR3032598T3 (fi) |
HK (1) | HK1014666A1 (fi) |
HU (1) | HU227339B1 (fi) |
IL (1) | IL114984A (fi) |
NO (1) | NO307814B1 (fi) |
NZ (1) | NZ272855A (fi) |
PL (1) | PL180691B1 (fi) |
RU (1) | RU2155044C2 (fi) |
SG (1) | SG30436A1 (fi) |
TW (1) | TW445152B (fi) |
ZA (1) | ZA957144B (fi) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060068017A1 (en) * | 1996-03-25 | 2006-03-30 | Wyeth | Extended release formulation |
US20030215507A1 (en) * | 1996-03-25 | 2003-11-20 | Wyeth | Extended release formulation |
US20040023948A1 (en) * | 1997-03-24 | 2004-02-05 | Green Richard David | Fast-dispersing dosage form containing 5-HT1 agonists |
GB9706089D0 (en) * | 1997-03-24 | 1997-05-14 | Scherer Ltd R P | Pharmaceutical composition |
US5895663A (en) * | 1997-07-31 | 1999-04-20 | L. Perrigo Company | Pseudoephedrine hydrochloride extended-release tablets |
CN100367965C (zh) * | 1999-12-20 | 2008-02-13 | 法布瑞-克雷默制药有限公司 | 吉吡隆代谢物在制备改善哺乳动物不良心理状态的组合物上的应用 |
US6534507B1 (en) * | 1999-12-20 | 2003-03-18 | Fabre-Kramer Pharmaceuticals, Inc. | Methods for treating psychological disorders using bioactive metabolites of gepirone |
CN1479620A (zh) * | 2000-12-08 | 2004-03-03 | ��˹��ŵ�� | 用于口服的延时释放的吉吡隆药剂 |
CZ20032959A3 (cs) * | 2001-05-01 | 2004-01-14 | Pfizer Products Inc. | Způsob přípravy farmaceutické kompozice s nízkou dávkou léčiva mající rovnoměrnou distribuci a účinnost léčiva |
PE20030527A1 (es) * | 2001-10-24 | 2003-07-26 | Gruenenthal Chemie | Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen |
US20030152621A1 (en) * | 2001-11-21 | 2003-08-14 | Egberink J. G. J. | Pharmaceutical formulation of gepirone for oral administration |
TW200306866A (en) * | 2002-05-07 | 2003-12-01 | Akzo Nobel Nv | A method to improve surface properties of pharmaceutical tablets |
AU2003274110A1 (en) * | 2002-09-24 | 2004-04-19 | Akzo Nobel N.V. | Method to improve pharmaceutical tablets having a matrix of cellulose ether |
CN1819821B (zh) | 2003-08-08 | 2010-10-13 | 拜奥维尔实验室国际股份有限公司 | 盐酸安非他酮的改良释放片剂 |
AR048112A1 (es) * | 2004-03-25 | 2006-03-29 | Solvay Pharm Bv | Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor |
AR049478A1 (es) * | 2004-03-25 | 2006-08-09 | Solvay Pharm Bv | Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas. |
US7799273B2 (en) | 2004-05-06 | 2010-09-21 | Smp Logic Systems Llc | Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes |
US7444197B2 (en) | 2004-05-06 | 2008-10-28 | Smp Logic Systems Llc | Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes |
US20060013874A1 (en) * | 2004-07-15 | 2006-01-19 | Solvay Pharmaceuticals B.V. | Extended release formulation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one |
PL1781292T3 (pl) * | 2004-07-15 | 2011-03-31 | Abbott Healthcare Products Bv | Formulacja o przedłużonym uwalnianiu 3-amino-8-(1-piperazynylo)-2H-1-benzopiran-2-onu |
JP2008519071A (ja) * | 2004-11-05 | 2008-06-05 | ファーブル−クレイマー・ホールディングス・インコーポレイテッド | ゲピロンの高用量徐放性製剤 |
US20060099267A1 (en) * | 2004-11-05 | 2006-05-11 | Fabre-Kramer Pharmaceuticals, Inc. | High-dosage extended-release formulation of gepirone |
EP1888080B1 (en) * | 2005-06-09 | 2010-04-14 | Euro-Celtique S.A. | Pharmaceutical compositions of a neuroactive steroid and uses thereof |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3870790A (en) * | 1970-01-22 | 1975-03-11 | Forest Laboratories | Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose |
GB1405088A (en) * | 1971-06-03 | 1975-09-03 | Mundipharma Ag | Slow release formulation |
US3965256A (en) * | 1972-05-16 | 1976-06-22 | Synergistics | Slow release pharmaceutical compositions |
US4226849A (en) * | 1979-06-14 | 1980-10-07 | Forest Laboratories Inc. | Sustained release therapeutic compositions |
US4357469A (en) * | 1979-06-14 | 1982-11-02 | Forest Laboratories, Inc. | Carrier base material for prolonged release therapeutic compositions |
US4248856A (en) * | 1979-07-10 | 1981-02-03 | American Home Products Corporation | Sustained release pharmaceutical compositions |
US4309406A (en) * | 1979-07-10 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
US4248858A (en) * | 1979-08-09 | 1981-02-03 | American Home Products Corporation | Sustained release pharmaceutical compositions |
US4547358A (en) * | 1980-05-06 | 1985-10-15 | Mead Johnson & Company | Sustained release tablet containing at least 95 percent theophylline |
US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
US4423049A (en) * | 1981-12-28 | 1983-12-27 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
US4415547A (en) * | 1982-06-14 | 1983-11-15 | Sterling Drug Inc. | Sustained-release pharmaceutical tablet and process for preparation thereof |
US4704284A (en) * | 1982-08-12 | 1987-11-03 | Pfizer Inc. | Long-acting matrix tablet formulations |
US4690824A (en) * | 1983-07-07 | 1987-09-01 | Redi-Rowell, Inc. | Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range |
US4610870A (en) * | 1984-10-05 | 1986-09-09 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
US4695591A (en) * | 1985-03-29 | 1987-09-22 | Schering Corporation | Controlled release dosage forms comprising hydroxypropylmethylcellulose |
SE460947B (sv) * | 1986-08-26 | 1989-12-11 | Lejus Medical Ab | En multiple-unit-dos komposition av l-dopa |
US4771053A (en) * | 1987-03-02 | 1988-09-13 | Bristol-Myers Company | Method for alleviation of primary depressive disorders |
US4782060A (en) * | 1987-07-29 | 1988-11-01 | Bristol-Myers Company | Gepirone for alleviation of panic disorders |
SE8703881D0 (sv) * | 1987-10-08 | 1987-10-08 | Haessle Ab | New pharmaceutical preparation |
SE8704097D0 (sv) * | 1987-10-22 | 1987-10-22 | Astra Ab | Oral formulation of buspirone and salts thereof |
US5106849A (en) * | 1988-05-24 | 1992-04-21 | American Home Products Corporation | Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of various central nervous system disorders |
US5096908A (en) * | 1990-05-04 | 1992-03-17 | Eli Lilly And Company | Method of inhibiting gastric acid secretion |
US5189179A (en) * | 1990-08-29 | 1993-02-23 | Merrell Dow Pharmaceuticals Inc. | Serotonin 5ht1a agonists |
US5124346A (en) * | 1991-04-23 | 1992-06-23 | Pfizer Inc. | Synergistic combinations in the treatment of anxiety |
US5169638A (en) * | 1991-10-23 | 1992-12-08 | E. R. Squibb & Sons, Inc. | Buoyant controlled release powder formulation |
US5292766A (en) * | 1992-03-25 | 1994-03-08 | Eli Lilly And Company | Method for improving primary memory and/or learning |
US5378846A (en) * | 1993-06-11 | 1995-01-03 | Russian-American Institute For New Drug Development | 1,2,3,4-tetrahydropyrrolo-[1,2-a]-pyrazine derivatives |
-
1994
- 1994-09-06 US US08/301,281 patent/US5478572A/en not_active Expired - Lifetime
-
1995
- 1995-08-16 TW TW084108546A patent/TW445152B/zh active
- 1995-08-16 NO NO953212A patent/NO307814B1/no not_active IP Right Cessation
- 1995-08-17 IL IL11498495A patent/IL114984A/xx not_active IP Right Cessation
- 1995-08-25 NZ NZ272855A patent/NZ272855A/en not_active IP Right Cessation
- 1995-08-25 ZA ZA957144A patent/ZA957144B/xx unknown
- 1995-08-28 ES ES95113476T patent/ES2142432T3/es not_active Expired - Lifetime
- 1995-08-28 AT AT95113476T patent/ATE186462T1/de active
- 1995-08-28 DK DK95113476T patent/DK0700680T3/da active
- 1995-08-28 DE DE69513254T patent/DE69513254T2/de not_active Expired - Lifetime
- 1995-08-28 EP EP95113476A patent/EP0700680B1/en not_active Expired - Lifetime
- 1995-08-31 CA CA002157323A patent/CA2157323C/en not_active Expired - Lifetime
- 1995-09-04 KR KR1019950028717A patent/KR100380806B1/ko not_active IP Right Cessation
- 1995-09-04 SG SG1995001280A patent/SG30436A1/en unknown
- 1995-09-05 CN CN95116203A patent/CN1096858C/zh not_active Expired - Fee Related
- 1995-09-05 CZ CZ19952275A patent/CZ286417B6/cs not_active IP Right Cessation
- 1995-09-05 FI FI954154A patent/FI117319B/fi not_active IP Right Cessation
- 1995-09-05 HU HU9502599A patent/HU227339B1/hu not_active IP Right Cessation
- 1995-09-05 RU RU95114742/14A patent/RU2155044C2/ru not_active IP Right Cessation
- 1995-09-05 JP JP22691095A patent/JP4540756B2/ja not_active Expired - Lifetime
- 1995-09-05 AU AU30438/95A patent/AU702282B2/en not_active Ceased
- 1995-09-06 PL PL95310298A patent/PL180691B1/pl not_active IP Right Cessation
-
1998
- 1998-12-28 HK HK98116037A patent/HK1014666A1/xx not_active IP Right Cessation
-
2000
- 2000-02-09 GR GR20000400296T patent/GR3032598T3/el unknown
-
2001
- 2001-05-04 CY CY0100008A patent/CY2222B1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL114984A (en) | Pharmaceutical composition useful for making an oral extended release gepirone dosage form | |
HUT62467A (en) | Process for producing locally applicable pharmaceutical compositions comprising allylamine derivative, against fungus infection of nails | |
AU646399B2 (en) | Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets | |
AU694647B2 (en) | Acetamide derivatives, process for producing the same, and medicinal composition containing the same | |
NO20073429L (no) | Anvendelse av et antistoff mot interleukin-6-reseptor for fremstilling av et farmasoytisk preparat | |
HU9402238D0 (en) | 1-benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives, process for producing them and pharmaceutical compositions containing them | |
CA2299231A1 (en) | Compressed nitroglycerin tablet and its method of manufacture | |
EP1258245A3 (en) | Accelerated release composition containing bromocriptine | |
AU2584192A (en) | Bone-growth-stimulating composition | |
RO116342B1 (ro) | Compoziţie farmaceutică lichidă, orală | |
CA2382387A1 (en) | Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure | |
AU2793989A (en) | Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained | |
KR900005964A (ko) | 분산성 제형 | |
CA2047744A1 (en) | Method for the synthesis of huperzine a and analogs thereof and compounds useful therein | |
AU2616795A (en) | Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl)propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients | |
IL145755A0 (en) | Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix | |
GR3018685T3 (en) | Method for the manufacture of a controlled release solid unit dosage form. | |
NO954952L (no) | Fremgangsmåte for fremstilling av en oral fast-stoff doseringsform som inneholder diklofenac | |
HUP9901260A3 (en) | Optically active phenylpyrimidine derivative as analgesic agent, process for producing it, pharmaceutical composition containing it and its intermediate | |
CA2344686A1 (en) | High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one | |
KR930021206A (ko) | 시타라빈 옥포스페이트 경질 캡슐제 | |
AU8104991A (en) | Gelatin coated medicament and process for making same | |
AU4329096A (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia | |
AU4898790A (en) | An erosion-controlled release system for active agents and a process for its preparation | |
AU6208594A (en) | Gastrokinetic agent, process for its preparation and pharmaceutical compositions containing said agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |